Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc (CURX) priced its initial public offering on Aug 26, 2025 at $4.00 per share, within its $4.00–$6.00 range, raising $15M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $111M. Dominari was lead-left underwriter, joined by Revere. Sichenzia Ross Ference Carmel advised the underwriters.

Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company discovering, developing and commercializing botanical drugs for inflammatory diseases, including immune and autoimmune conditions, using natural substances.

Status

IPO

Ticker

CURX

Exchange

Nasdaq Capital Market

Priced

Aug 26, 2025

IPO price

$4.00

Price range

$4.00–$6.00

Raised

$15M

Market cap at IPO price

$111M

First filed

Oct 16, 2024

Underwriters

Dominari and Revere

Underwriters' counsel

Sichenzia Ross Ference Carmel

Sector

Biotech & pharma

Country / state

NY

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.